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 Tubulointerstitial fi brosis is seen as the 
fi nal common pathway leading to end-
stage renal failure irrespective of the etiol-
ogy of the underlying kidney disease. 
Great emphasis, therefore, has been 
placed on understanding the mechanisms 
regulating renal fi brosis, with many stud-
ies focusing on the role of growth factors, 
hypoxia, matrix degradation and synthe-
sis, and fi broblast transition, migration, 
and proliferation. 1 However, one possible 
mechanism that has received relatively 
little attention is that of T cells exerting a 
direct eff ect on the fi brotic process. 
 In kidney disease, T cells are best 
known for their role in causing acute and 
chronic renal injury, particularly immune-
mediated glomerular injury. 2 Further-
more, progressive tubulointerstitial 
fi brosis is invariably associated with inter-
stitial infi ltration of T cells and macro-
phages in human and experimental 
kidney disease, implying a role for these 
immune cells in the fi brotic process. 3,4 
Th us, it is diffi  cult to defi ne a direct role 
for T cells in promoting renal fi brosis, 
since, in many diseases, T cells play a 
 necessary role in causing renal injury to 
which fi brosis is the response. However, 
there is evidence that T cells promote 
 tissue fi brosis in nonrenal diseases, such 
as hepatic fi brosis. 5 
 Delineating the role of T cells in renal 
fi brosis requires a model in which the 
injury that induces renal fi brosis is inde-
pendent of T cells. Unilateral ureteric 
obstruction (UUO) is a model commonly 
used for the study of interstitial fi brosis, 
which has the specifi c advantage that the 
fi brotic response is secondary to mecha-
nical damage with no obvious role for 
adaptive immunity in the primary renal 
injury. The UUO model also shows a 
robust and rapid development of intersti-
tial fi brosis, making it the model of choice 
for most studies of renal fi brosis. Th e role 
of lymphocytes in this model was fi rst 
examined by Shappell  et al. , 6 using severe 
combined immunodefi cient (SCID) mice, 
which lack T and B lymphocytes. SCID 
and wild-type mice show the same degree 
of interstitial volume expansion — a 
parameter that correlates well with the 
degree of fi brosis in this model — at mul-
tiple time points following UUO, arguing 
that lymphocytes do not contribute to 
interstitial fi brosis. 6 
 Th e role of T cells in the UUO model has 
now been reexamined by two independent 
studies. Using SCID mice (on a genetic 
background diff erent from that used by 
Shappell  et al. 6 ), Niedermeier  et al. 7 have 
recently shown that lymphocyte defi ciency 
caused a substantial reduction in collagen I 
deposition in the obstructed kidney. In 
addition, they found that anti-CD4 anti-
body treatment of wild-type mice deleted 
CD4   +   T cells and caused a minor, but sta-
tistically signifi cant, reduction in collagen 
I deposition in the obstructed kidney. 7 Th is 
protective eff ect was associated with a 
reduction in renal accumulation of leu-
kocyte-derived fi brocytes, which produce 
collagen I (the main focus of the study). 
However, this particular observation may 
be of limited importance in understand-
ing the mechanisms by which T cells pro-
mote renal fi brosis, as leukocyte-derived 
fi brocytes account for fewer than 1 % of 
the collagen-producing fi broblast-type 
cells in this model. 8,9 
 Tapmeier  et al. 10 (this issue) now present 
evidence to support a role for CD4   +   T cells 
in causing interstitial fibrosis in the 
obstructed kidney, based on two strategies: 
reconstitution of lymphocyte-deficient 
mice with CD4   +   T cells, and administra-
tion of a depleting anti-CD4 antibody in 
wild-type mice. 
 Mice with a non-functional recombi-
nase activating gene 1 ( RAG   −  /  −   ) are 
lymphocyte defi cient and are broadly con-
sidered equivalent to SCID mice.  RAG   −  /  −  
mice exhibited a signifi cant reduction in 
interstitial collagen deposition compared 
with UUO wild-type mice as assessed by 
Masson trichrome staining. 10 Th is was 
accompanied by a comparable reduction 
in the number of   -smooth muscle actin 
(  -SMA)-expressing myofibroblasts, 10 
the cell type that accounts for 99 % of the 
tubulointerstitial collagen I-expressing 
cells in the obstructed kidney. 8 Upregula-
tion of transforming growth factor-  1 
mRNA levels correlates closely with the 
degree of interstitial fi brosis in this model, 
but surprisingly, this was not altered in 
UUO  RAG   −  /  −   mice, although a minor 
reduction in collagen I mRNA was evi-
dent. Tapmeier  et al. 10 found no diff erence 
in tubular damage and no diff erence in 
the number of F4 / 80   +   macrophages, 
although this latter point is diffi  cult to 
interpret since macrophage function is 
critically dependent on phenotype rather 
than simply cell number. Indeed, the role 
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of macrophages in causing renal fi brosis 
in this particular model is controversial, 
with studies for and against; 11,12 however, 
it could be argued that the reduction in 
renal fi brosis in the  RAG   −  /  −   mice could 
be the result of a less profi brotic pheno-
type in the macrophage infi ltrate (a point 
acknowledged by Tapmeier  et al. ). Th is 
question is worthy of further study. 
 In order to distinguish which lym-
phocyte population is responsible for 
promoting renal fi brosis,  RAG   −  /  −   mice 
were reconstituted with splenic CD4   +   or 
CD8   +   T cells. 10 CD4   +   T cell-reconsti-
tuted  RAG   −  /  −   (CD4   +    RAG   −  /  −   ) mice 
exhibited signifi cantly more severe renal 
fi brosis than unmodifi ed  RAG   −  /  −   mice, 
with interstitial expansion, interstitial 
collagen deposition, and upregulation 
of collagen I mRNA levels being compar-
able to those seen in wild-type UUO 
mice — providing an argument that 
CD4   +   T cells promote interstitial fi brosis 
in this model. In contrast, CD8   +    RAG   −  /  −  
mice did not show any diff erence in colla-
gen deposition or other fi brotic para-
meters as compared with unmodifi ed 
 RAG   −  /  −   mice, suggesting that CD8   +  
T cells are not involved in the fi brotic 
response, or need cooperation with other 
T-cell populations. 10 
 Although the degree of tubular damage 
in the CD4   +    RAG   −  /  −   mice was similar to 
that in the other groups, one diff erence 
was that the CD4   +   T cell infi ltrate was 
fi vefold greater than in wild-type mice, 
raising questions about whether these 
CD4   +   T cells have the same phenotype as 
the infiltrate seen in wild-type mice. 10 
Another puzzling aspect is the mechanism 
by which fi brosis is enhanced in CD4   +  
 RAG   −  /  −   mice. Interstitial   -SMA   +   myo-
fibroblasts are the major population 
responsible for matrix production in 
interstitial fi brosis, including collagen I 
expression. 8,13 However, CD4   +    RAG   −  /  −  
mice show a reduction in   -SMA   +   myo-
fi broblasts — signifi cantly below even that 
seen in CD8   +    RAG   −  /  −   and unmodifi ed 
 RAG   −  /  −   mice — and yet CD4   +    RAG   −  /  −  
mice exhibit a signifi cant increase in col-
lagen deposition and collagen I mRNA 
levels. 10 Th us, CD4   +    RAG   −  /  −   mice show 
an increase in interstitial fi brosis, which is 
accompanied by a reduction in the cell 
type thought to be primarily responsible 
for this fi brosis. 
 One possible explanation of this fi nd-
ing is that the CD4   +   T cell infiltrate 
blocked differentiation of interstitial 
  -SMA   −   fi broblasts into   -SMA   +   myofi -
broblasts without aff ecting upregulation 
of collagen I mRNA. This could be 
addressed with the use of alternative 
markers to identify interstitial fi broblast 
populations (for example, FSP1, vimen-
tin, ecto-5  -nucleotidase, and Hsp47). A 
second, though substantially less plausi-
ble, possibility is that CD4   +   T cells 
caused an increase in collagen produc-
tion by tubular epithelial cells. Such a 
mechanism could be due to local trans-
forming growth factor-  1 generation by 
CD4   +   T cells. 
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 Figure 1  |  Schematic diagram illustrating the potential role of T cells in interstitial fibrosis. It is 
now evident that virtually all of the collagen-producing   -smooth muscle actin-positive (  -SMA   +   ) 
myofibroblasts in the interstitium of the obstructed kidney are derived through proliferation and 
differentiation of resident pericytes and fibroblast populations. 14 This process may be modulated 
by T cells by at least three non-exclusive mechanisms. (1) T cells may act directly on renal fibroblasts 
and pericytes (possibly via transforming growth factor-  1 (TGF-  1)) to promote their migration, 
proliferation, and differentiation, resulting in the accumulation of   -SMA   +   myofibroblasts, which 
synthesize and deposit interstitial matrix. (2) T cells may induce a profibrotic phenotype in the infiltrating 
macrophage population, which, in turn, secrete pro-proliferative and profibrotic cytokines and growth 
factors (for example, PDGF, TGF-  1, and CTGF) that induce fibroblast migration, proliferation, and 
differentiation. (3) T cells may act directly on tubular epithelial cells to induce secretion of cytokines and 
growth factors that, in turn, act on fibroblasts. Abbreviations: CTGF, connective tissue growth factor; 
FGF-2, fibroblast growth factor-2; PDGF, platelet-derived growth factor. 
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 Tapmeier  et al. 10 also used anti-CD4 
antibody treatment in wild-type UUO 
mice, which caused at least a 50 % reduc-
tion in collagen deposition, providing a 
 prima facie case for CD4   +   T cells pro-
moting interstitial fi brosis in this model. 
The CD4 antibody treatment did not 
alter tubular damage or the number of 
F4 / 80   +   macrophages, consistent with the 
 RAG   −  /  −   studies. Intriguingly, the CD4 
antibody treatment resulted in a twofold 
increase in the interstitial   -SMA   +  
myofibroblast population, while sup-
pressing renal fi brosis. 10 Th us, removal 
of all lymphocytes in  RAG   −  /  −   mice sup-
pressed interstitial fibrosis in the 
obstructed kidney together with a reduc-
tion in   -SMA   +   myofi broblasts, whereas 
depletion of CD4   +   T cells using antibody 
treatment also reduced fi brosis but with 
an increase in   -SMA   +   myofi broblasts. 
Th ese apparently contradictory results 
are diffi  cult to reconcile, and a further 
complicating factor is the short duration 
of CD4 antibody treatment such that 
CD4 T cells reappeared in the obstructed 
kidney later in the disease course. 
 In summary, two recent studies pro-
vide evidence, particularly by the use of 
depleting CD4 antibody treatment, that 
CD4   +   T cells promote renal fi brosis in 
the obstructed kidney. 7,8 Many questions 
remain regarding the potential mecha-
nisms involved in this process. As illus-
trated in  Figure 1 , there are at least three 
potential mechanisms by which CD4   +   T 
cells may promote renal fibrosis. It is 
hoped that these intriguing studies will 
stimulate further research into the direct 
actions in T cells in renal fi brosis — a path-
ologic process that is in desperate need of 
innovative therapies. 
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 In this issue of  Kidney International , 
Lertdumrongluk  et al. 1 examine the rela-
tionship between the pharmacokinetics 
of mycophenolic acid (MPA) and the 
response to treatment in patients with 
class III and IV lupus nephritis (Interna-
tional Society of Nephrology / Renal 
Pathology Society category). Th e topic 
of therapeutic drug monitoring (TDM) 
of MPA and the effi  ciency of the therapy 
in lupus nephritis treatment with the use 
of mycophenolate mofetil (MMF) and 
enteric-coated mycophenolate sodium 
(EC-MPS) warrants further attention. 
 Lupus nephritis is a kidney disorder 
affecting approximately three of every 
10,000 people. Th e medical therapy for 
lupus nephritis depends on the severity of 
the disease. In general, corticosteroids are 
prescribed for mild disease, whereas more 
severe disease requires treatment with 
immunosuppressive drugs. Th e two most 
commonly used agents are MMF and 
intravenous cyclophosphamide. In a 
recent study, patients with class III and IV 
 Therapeutic drug monitoring of 
mycophenolic acid: a potential 
treatment for lupus nephritis 
 Tomasz  Pawinski 1 
 Mycophenolate mofetil, an immunosuppressant approved for the 
prevention of transplant rejection, has been used in patients with lupus 
nephritis. Lertdumrongluk  et al. 1 suggest that mycophenolic acid 
exposure may predict therapeutic responses in severe lupus nephritis, 
and their initial results confirm that hypothesis. However, it seems that 
enteric-coated mycophenolate sodium should not be administered to 
patients provided with therapeutic drug monitoring. 
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